Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. EFFECT Other Notice of Effectiveness
  4. POSASR Other POSASR
  5. POSASR Other POSASR
  6. POS AM Other Post-effective Amendment for Registration Statement
  7. S-8 POS Other Post-effective Amendment
  8. S-8 POS Other Post-effective Amendment
  9. S-8 POS Other Post-effective Amendment
  10. S-8 POS Other Post-effective Amendment
  11. S-8 POS Other Post-effective Amendment
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 POS Other Post-effective Amendment
  15. S-8 POS Other Post-effective Amendment
  16. 8-K12G3 Other 8-K12G3
  17. EFFECT Other Notice of Effectiveness
  18. F-6/A Other F-6/A
  19. F-6 Other Registration of American Depositary Receipt Shares
  20. 144 Insider Sale of Securities

Page 5 of 11 · 207 filings